Surgery for Cochlear Implantation

Chapter 31 Surgery for Cochlear Implantation



image Videos corresponding to this chapter are available online at www.expertconsult.com.


There have been remarkable advances in cochlear implantation. Although the first attempt to stimulate the auditory system electrically occurred nearly 2 centuries ago, the development of a cochlear prosthesis to restore hearing to patients with sensorineural hearing loss has happened only over the past 5 decades. The early pioneering work of Simmons, Michaelson, and House provided the stimulus to encourage others, including Bonfai, Chouard, Clark, Eddington, and the Hochmairs.1 The initial acceptance of cochlear implants was slow; safety and efficacy were the concerns of the early investigators, and the greatest champions of the implant were the patients themselves. Time and technology have increased the benefits gained by most patients from their cochlear implants. As a result, cochlear implants have become the most successful prosthesis ever used to attempt to restore a sensory deficit.


As of the writing of this chapter, more than 120,000 patients have received cochlear implants worldwide. More than 50,000 patients have received cochlear implants in the United States. In the United States, the Food and Drug Administration (FDA) regulates the manufacturers of cochlear implants. The FDA has approved devices from Advanced Bionics Corporation (Sylmar, CA), Cochlear Corporation (New South Wales, Australia), and MED-EL Corporation (Innsbruck, Austria) for use in adults and children.


Incremental improvements in technology have resulted in the approval of multiple devices over the years. As performance with cochlear implants has improved over the years, the criteria for cochlear implantation have expanded (Table 31-1). In more challenging situations, bilateral cochlear implantation has been shown to provide additional benefit beyond a single cochlear implant, and is now considered an accepted medical practice outside of research protocols.2 Prospective studies continue to examine the benefits of bilateral cochlear implantation in adults and children.





MEDICAL EVALUATION


A thorough medical evaluation is necessary to detect problems that may contraindicate surgery or interfere with the patient’s ability to complete postimplantation rehabilitation. Rarely, the cause of hearing loss may be a contraindication to surgery. Aplasia of the cochlea and aplasia of the cochlear nerve are contraindications to surgery because there are no auditory nerve elements to receive stimulus from the implant. A prior history of meningitis with cochlear ossification or fibrosis does not exclude the patient from implantation, but may necessitate modification of the surgical technique.


Two crucial factors influencing auditory performance after cochlear implantation include age of onset of deafness and duration of profound hearing loss. The ideal adult candidate has profound acquired sensorineural hearing loss. A period of auditory experience adequate for development of normal speech, speech perception, and language offers a significant advantage in learning to use the implant. These postlingually deafened patients represent most adults undergoing cochlear implantation. In these patients, there is a significant correlation between duration of profound hearing loss and performance.3 Patients with prolonged auditory deprivation receive similar auditory information as do other implant patients, but are unable to use the information as effectively; this is thought to be due to the loss of central auditory processing. A few adult implant recipients are congenitally or prelingually deafened, with prolonged auditory deprivation and little to no experience with sound. These patients typically have greater difficulty assimilating the new auditory information, and generally have performed less well than patients with some degree of auditory memory.


The presence of auditory memory associated with delayed onset of deafness also correlates with improved speech and language skills in children after cochlear implantation. Congenitally deafened children receive the maximal auditory benefit from cochlear implantation by undergoing cochlear implantation at the youngest age possible. Current FDA guidelines require a child to be at least 1 year old, have profound sensorineural hearing loss, show no benefit from conventional hearing aids, and be free from medical contraindications. In addition to these criteria, the commitment of the family and the child’s educational setting to postimplantation rehabilitation is a crucial determinant of successful implant use.





Imaging


Preoperative imaging completes the candidacy evaluation process and assists in surgical planning. Choice of imaging modality varies at individual implant centers. High-resolution computed tomography (CT) scanning of the temporal bone and magnetic resonance imaging (MRI) are currently used. CT scanning provides excellent detail of inner ear morphology, the course of the intratemporal facial nerve, and aeration of the mastoid. Limitations of CT include the inability to evaluate retrocochlear pathology and cochlear patency in patients with fibrosis of the cochlea as a precursor to cochlear ossification. The ability to detect an absent cochlear nerve also is limited. MRI addresses these limitations,6 but this imaging modality incurs additional expense and may require general anesthesia in young patients.


Complete agenesis of the cochlea and an abnormal acoustic nerve resulting from congenital malformation, trauma, or surgery are contraindications for cochlear implant placement.7 Cochlear hypoplasia (present in Mondini’s deformity) is not a contraindication for cochlear implantation. Adults and children with incomplete congenital cochlear malformations have received implants successfully.8 Ossification or fibrous occlusion of the cochlea or the round window does not exclude a patient from implantation, but it may influence outcome. Occlusion of the cochlea may lead to partial insertion of the electrode carrier. MRI has become more useful than CT in the evaluation of the membranous inner ear in detecting cochlear fibrosis.



Promontory Evaluation


A few implant teams perform an electric stimulation test at either the promontory or the round window membrane.9 A positive response is a perception of sound on stimulation. Some investigators do not believe that such testing is crucial in the selection of candidates because patients with a negative response, particularly at the promontory, may respond to intracochlear stimulation with an implant. Promontory stimulation may be helpful in cases of suspected cochlear nerve agenesis.




SURGICAL TECHNIQUE


The cochlear implant should be implanted only by qualified surgeons specifically trained to perform the procedure. Although specific details of implantation vary based on the device implanted, the general approach to implantation is the same.


The implant is inserted via a transmastoid facial recess approach to the round window and scala tympani. Placement of cochlear implants in children is essentially the same as in adults. By age 1 year, the mastoid antrum and facial recess are adequately developed. In patients with mastoid cavities or absent posterior ear canal, obliteration of the mastoid cavity with blind sac closure of the external auditory canal is preferably done at the time of disease removal. Cochlear implant placement is performed at a second stage approximately 4 to 6 months later.


Surgery is performed with the patient under general anesthesia with the use of continuous intraoperative facial nerve monitoring. Perioperative antibiotics are routinely administered before making the initial incision. Many different incisions have been designed to allow placement of the receiver-stimulator (Fig. 31-1). Generally, the skin flap must be large enough to cover the receiver-stimulator completely. The length of the incision and size of the skin flap have been reduced over the years. By reducing incision and flap size, there is less interruption of the vascular supply to the operative field; this seems to correlate with fewer wound and flap complications. Skin and periosteal incisions should overlap by at least 1 cm; the skin incision should be at least 1 cm anterior to the front edge of the receiver-stimulator (Fig. 31-5).


Stay updated, free articles. Join our Telegram channel

Jun 14, 2016 | Posted by in OTOLARYNGOLOGY | Comments Off on Surgery for Cochlear Implantation

Full access? Get Clinical Tree

Get Clinical Tree app for offline access